Florence Italy
Hospitality · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.florencefreetours.comRevenue
<$5 MillionIndustry
About Florence Italy
Is Florence Italy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Florence Italy has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Florence Italy has new funding data
Florence Italy, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Florence Italy is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Florence Italy had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Florence Italy
Earning: See what the market has to say on Florence Italy recently announced quarterly report
Product Launch: Get notified when Florence Italy launches new products
Recommended Actions
Find VP level buyers at Florence Italy
Find more new buyers
Compare Similar Companies to Florence Italy
Compare insights from companies similar to Florence Italy, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Florence Italy
Company Profile Activity
Activity Insights
Florence Italy is experiencing very low activity levels compared to other companies in the Hospitality sector.
What does this means?
Florence Italy is drawing exceptional interest within the Hospitality industry, suggesting notable developments or strong market momentum, learn more about Florence Italy.
Florence Italy Tech Stack
A closer look at the technologies used by Florence Italy
Florence Italy News & Media
A. Menarini Diagnostics and Nucleix Announce a Strategic Partnership for a Non-Invasive Bladder Cancer Test in Europe
FLORENCE, Italy & SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--A. Menarini Diagnostics, a company bringing advanced solutions to the in vitro diagnostic market, and Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced at the 36th European Congress of Pathology in Florence, that they have entered into a long-term commercial agreement for the exclusive distribution of the Bladder EpiCheck® test in Europe. This non-invasive CE-marked test dMenarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
FLORENCE, Italy & NEW YORK--(BUSINESS WIRE)--The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, will present updated results from phase 1b/2 ELECTRA and ELEVATE clinical studies evaluating elacestrant (ORSERDU®) in combination with other treatments. Both the ELECTRA and ELEVATE stMenarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications
FLORENCE, Italy & NEW YORK--(BUSINESS WIRE)--The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, along with clinical stage generative artificial intelligence (AI)-driven biotechnology company Insilico Medicine (“Insilico”), today announced that they have entered into an exclusive liMenarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium
FLORENCE, Italy & NEW YORK--(BUSINESS WIRE)--The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, presented results from phase 1b/2 ELEVATE and ELECTRA clinical studies evaluating ORSERDU® (elacestrant) in combination with other treatments. Both the ELEVATE and ELECTRA studies were
Top Hospitality Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Florence Italy
Florence Free Tours offers exceptional free walking tours in Florence, Italy, showcasing the city's rich history and artistic heritage. Led by knowledgeable local guides, the tours cover iconic landmarks such as the Duomo, Ponte Vecchio, and the Uffizi Gallery. The company promises a unique experience where participants only pay if they are satisfi... Read More